journal article·2020-04-12

Preparation and characterization of a Schiff-based chitosan-fructose quaternary ammonium salt for medical applications

Yu Yi, Jiacheng Fei, Yun-Xia Xu, Guoqing Ying, Zhi-Min Ou

Publisher page

Abstract

The aim of this study was to develop a new chitosan derivative and investigate its effects on fresh tissue healing in rats. A chitosan-fructose Schiff based quaternary ammonium salt (CS = Fru-DEAE) was synthesized for the first time and characterized using FT-IR and 1HNMR, and the modification rate and the solution properties were studied. A rat wound model was established, and the experimental group was treated using 0.1 g of the chitosan derivative hydrogel. The wound healing rate, and the concentration of collagen III and proline in the wounds were assessed in the experimental group and compared with those of the control group at 7, 10, and 15 d. The CS = Fru-DEAE hydrogel demonstrated good performance and promoted the healing of infected wounds in rats. The hydrogel could accelerate the infiltration of inflammatory cells and increase the amount of type III collagen in the wound area, which likely contributed to its efficacy.
Source: openalex_inverted_index · Quality: baseline

Research context

OpenAlex topics: Nanocomposite Films for Food Packaging · Wound Healing and Treatments · Silk-based biomaterials and applications

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

Affiliations

College of Pharmacy, Zhejiang University of Technology, Hangzhou, China

References (19)

Show source-provided references
1. 10.1016/j.ijbiomac.2018.03.01710.1016/j.ijbiomac.2018.03.017 ↗
2. 10.1016/j.carbpol.2017.10.02110.1016/j.carbpol.2017.10.021 ↗
3. 10.1016/j.ijbiomac.2016.02.03610.1016/j.ijbiomac.2016.02.036 ↗
4. 10.1016/j.biomaterials.2013.11.08110.1016/j.biomaterials.2013.11.081 ↗
5. 10.3390/md1412023410.3390/md14120234 ↗
6. 10.3390/md1304215810.3390/md13042158 ↗
7. 10.1007/s13197-015-1780-910.1007/s13197-015-1780-9 ↗
8. 10.1016/j.apsusc.2016.02.05310.1016/j.apsusc.2016.02.053 ↗
9. 10.5301/jabfm.500027610.5301/jabfm.5000276 ↗
10. Lin T · Biomater Sci · 2018 · 6
11. 10.1155/2017/679641210.1155/2017/6796412 ↗
12. 10.1016/j.ijpharm.2016.06.01610.1016/j.ijpharm.2016.06.016 ↗
13. 10.1016/j.ijbiomac.2017.01.11910.1016/j.ijbiomac.2017.01.119 ↗
14. 10.1016/j.colsurfa.2017.06.07410.1016/j.colsurfa.2017.06.074 ↗
15. Gilman T · Br J Dermatol · 2015 · 142 · 960
16. Tarek A · Dev Therapy · 2016 · 10 · 483
17. 10.1002/1097-4636(20000915)51:4<586::AID-JBM6>3.0.CO;2-S10.1002/1097-4636(20000915)51:4<586::AID-JBM6>3.0.CO;2-S ↗
18. Grzegorz F · Front Microbiology · 2016 · 7 · 1258
19. 10.3390/md1303113310.3390/md13031133 ↗